GlassScriptPhysician profile
Dominic Aro
NPI 1780638858
$2,848.87
in general payments reported to CMS, 2019-2025
25 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $415 · 2021: $548 · 2022: $680 · 2023: $418 · 2024: $33.52 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,000.29 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $281.95 | 2019-2023 | Slynd, Nuvessa |
| Mayne Pharma Commercial LLC | $229.12 | 2021-2025 | |
| Therapeuticsmd, INC. | $156.67 | 2020-2022 | |
| Myovant Sciences INC. | $149.88 | 2022 | |
| Allergan, INC. | $127.93 | 2019-2020 | |
| Pfizer INC. | $117.41 | 2022-2024 | |
| Avion Pharmaceuticals | $116.53 | 2019-2022 | |
| Astellas Pharma US INC | $116.19 | 2022-2024 | Veozah |
| Hologic Sales and Service, LLC | $100.35 | 2019-2025 | Aptima |
| Sumitomo Pharma America, INC. | $72.38 | 2023 | Myfembree, Gemtesa |
| Lupin INC. | $69.36 | 2019-2020 | |
| Urovant Sciences INC | $62.43 | 2021-2022 | |
| Ethicon US, LLC | $40.64 | 2021-2025 | Surgiflo Hemostatic Matrix |
| Meditrina | $30.93 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $24.58 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $22.22 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $19.81 | 2023 | Kristalose |
| Covidien LP | $18.39 | 2020 | |
| Vertical Pharmaceuticals, LLC | $17.25 | 2019 | |
| Organon LLC | $16.51 | 2025 | Nexplanon |
| Coopersurgical, INC. | $16.10 | 2019 | |
| Novo Nordisk INC | $14.72 | 2019 | |
| Lsi Solutions INC | $14.33 | 2019 | |
| Eisai INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominic Aro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.